To dissect the exact molecular mechanisms involved in the combined effect of STYK1 knockdown and EGFR TKI treatment in NSCLC cells, we performed RNA sequencing (RNAseq) analyses. The gene discussed is STYK1; the disease is non-small cell lung carcinoma.